Akèy › Maladi kadyovaskilè › Maryland
Etid klinik pou Maladi kadyovaskilè nan Maryland
31 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyiMande peman pou patisipan yo
Laj 19 a 85 · Tout sèks · Mizajou Oct 2, 2026 · NCT01927783Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 70 · Tout sèks · Mizajou Oct 2, 2026 · NCT03374215New Heart Imaging Techniques to Evaluate Possible Heart Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01399385EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Ascension Saint Agnes Heart Care, Baltimore
- Medstar Montgomery Medical Center, Olney
- MD Medical Research, Oxon Hill
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473Diabetes and Heart Disease Risk in Blacks
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001853Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MedStar Southern Maryland Hospital Center, Clinton
- Capitol Cardiology Associates PA, Lanham
- Shady Grove Adventist Hospital, Rockville
- ak 3 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT07613099Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT02543996Product Surveillance Registry
- Hyattsville
- Salisbury
- Silver Spring
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Baltimore
- Clinical Trial Site, Baltimore
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 18, 2026 · NCT05440422Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 25 · Tout sèks · Mizajou Sep 17, 2026 · NCT06730113Zenith® Fenestrated+ Clinical Study
- University of Maryland, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT04875429Natural History Study of CADASIL
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05072483Technical Development of Cardiovascular Magnetic Resonance Imaging
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT04927429Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- The Johns Hopkins Hospital, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT03242642Thrombosis and Inflammation in Vessels Initiative (TIVI)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 5 a 100 · Tout sèks · Mizajou Sep 10, 2026 · NCT06552767Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Maryland Medical Center, Baltimore
- The Johns Hopkins Hospital, Baltimore
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 8, 2026 · NCT03372733Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 8, 2026 · NCT04216342An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- University of Maryland, Baltimore
- Sinai Ct for Throm Res and Drug Dev, Baltimore
- Johns Hopkins Univ School of Med, Baltimore
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Johns Hopkins University, Baltimore
Ap rekriteFaz 4Volontè an sante akeyi
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- University of Maryland/Greenebaum Cancer Center, Baltimore
Ap rekriteEtid obsèvasyon
Laj 7 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Annapolis
- Research Site, Baltimore
- Research Site, Baltimore
- ak 9 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins Hospital, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- ak 5 plis
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Flourish Research Bowie, Bowie
- Anderson Medical Research, Ft. Washington
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911The Oxford Risk Factors And Non-Invasive Imaging Study
- NIH National Heart, Lunch, and Blood Institute, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Jul 31, 2026 · NCT05169333PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- MedStar, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- Flourish Bowie, Bowie
Ap rekriteFaz 3
Laj 35 a 80 · Tout sèks · Mizajou Apr 16, 2026 · NCT07293260The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Johns Hopkins, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation Participation
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Bayview Medical Center, Baltimore
- Johns Hopkins Hospital, Baltimore
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06908590Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.